Concepedia

Thierry T. Diagana

TT

Statistics

Publications

55

Citations

6.6K

H-Index

39

Active since

1995

Affiliations

Novartis (Singapore)(Current)

Novartis (Switzerland)

Novartis (United States)

Genomics Institute of the Novartis Research Foundation

Swiss Tropical and Public Health Institute

Thierry T. Diagana is an author at Novartis (Singapore) specializing in pharmacology, drug discovery, and malaria parasites.

ORCID

Publications per year

1995–2024

55

Publications

55

Spiroindolones, a Potent Compound Class for the Treatment of Malaria

Matthias Rottmann, Case W. McNamara, Bryan K. S. Yeung et al. · Science · 2010 · 1.2K citations · Full text

, , +16

Targeting Plasmodium PI(4)K to eliminate malaria

Case W. McNamara, Chek Shik Lim, Siau Hoi Lim et al. · Nature · 2013 · 426 citations · Full text

, , +12

Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria

Bryan K. S. Yeung, Bin Zou, Matthias Rottmann et al. · Journal of Medicinal Chemistry · 2010 · 425 citations · Full text

, , +16

Imaging of <i>Plasmodium</i> Liver Stages to Drive Next-Generation Antimalarial Drug Discovery

Stephan Meister, David Plouffe, Kelli Kuhen et al. · Science · 2011 · 347 citations · Full text

, , +16

Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials

Natalie J. Spillman, Richard J. Allen, Case W. McNamara et al. · Cell Host & Microbe · 2013 · 248 citations · Full text

, , +17

1–5 of 55